Table of contents
Volume 94, Issue 12
Published online 13 June 2006 (1765-1963)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Letters to the Editor |
Indexes
Minireview
AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL FREE
E Weisberg, P Manley, J Mestan, S Cowan-Jacob, A Ray and J D Griffin
Br J Cancer 94: 1765-1769; advance online publication, May 23, 2006; doi:10.1038/sj.bjc.6603170
Clinical Studies
Long-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphoma FREE
F Buchegger, C Antonescu, A Bischof Delaloye, C Helg, T Kovacsovics, M Kosinski, J-P Mach and N Ketterer
Br J Cancer 94: 1770-1776; advance online publication, May 9, 2006; doi:10.1038/sj.bjc.6603166
Efaproxiral red blood cell concentration predicts efficacy in patients with brain metastases FREE
B Stea, E Shaw, T Pintér, J Hackman, M Craig, J May, R P Steffen and J H Suh
Br J Cancer 94: 1777-1784; doi:10.1038/sj.bjc.6603169
An approach to estimating prognosis using fractional polynomials in metastatic renal carcinoma FREE
P Royston, M Reitz and J Atzpodien
Br J Cancer 94: 1785-1788; advance online publication, May 30, 2006; doi:10.1038/sj.bjc.6603192
Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials FREE
G Ferretti, E Bria, D Giannarelli, A Felici, P Papaldo, A Fabi, S Di Cosimo, E M Ruggeri, M Milella, M Ciccarese, F L Cecere, A Gelibter, C Nuzzo, F Cognetti, E Terzoli and P Carlini
Br J Cancer 94: 1789-1796; advance online publication, May 30, 2006; doi:10.1038/sj.bjc.6603194
Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study FREE
A López-Pousa, R Losa, J Martín, J Maurel, J Fra, M Sierra, A Casado, J García del Muro, A Poveda, C Balañá, J Martínez-Trufero, E Esteban and J M Buesa
Br J Cancer 94: 1797-1802; advance online publication, May 23, 2006; doi:10.1038/sj.bjc.6603187
Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer FREE
K Yamaguchi, T Shimamura, I Hyodo, W Koizumi, T Doi, H Narahara, Y Komatsu, T Kato, S Saitoh, T Akiya, M Munakata, Y Miyata, Y Maeda, H Takiuchi, S Nakano, T Esaki, F Kinjo and Y Sakata
Br J Cancer 94: 1803-1808; doi:10.1038/sj.bjc.6603196
Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I–II study FREE
A Avallone, P Delrio, C Guida, F Tatangelo, A Petrillo, P Marone, L G Cascini, B Morrica, S Lastoria, V Parisi, A Budillon and P Comella
Br J Cancer 94: 1809-1815; advance online publication, May 30, 2006; doi:10.1038/sj.bjc.6603195
Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients FREE
M Shioiri, T Shida, K Koda, K Oda, K Seike, M Nishimura, S Takano and M Miyazaki
Br J Cancer 94: 1816-1822; doi:10.1038/sj.bjc.6603193
Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature FREE
G Des Guetz, B Uzzan, P Nicolas, M Cucherat, J-F Morere, R Benamouzig, J-L Breau and G-Y Perret
Br J Cancer 94: 1823-1832; doi:10.1038/sj.bjc.6603176
Translational Therapeutics
The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer FREE
J E M Crozier, R F McKee, C S McArdle, W J Angerson, J H Anderson, P G Horgan and D C McMillan
Br J Cancer 94: 1833-1836; advance online publication, May 23, 2006; doi:10.1038/sj.bjc.6603185
Different susceptibility of osteosarcoma cell lines and primary cells to treatment with oncolytic adenovirus and doxorubicin or cisplatin FREE
H C A Graat, M A Witlox, F H E Schagen, G J L Kaspers, M N Helder, J Bras, G R Schaap, W R Gerritsen, P I J M Wuisman and V W van Beusechem
Br J Cancer 94: 1837-1844; advance online publication, May 30, 2006; doi:10.1038/sj.bjc.6603189
Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-
FREE
D Ribatti, B Nico, A Pezzolo, A Vacca, R Meazza, R Cinti, B Carlini, F Parodi, V Pistoia and M V Corrias
Br J Cancer 94: 1845-1852; advance online publication, May 23, 2006; doi:10.1038/sj.bjc.6603186
Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment FREE
C Wibom, F Pettersson, M Sjöström, R Henriksson, M Johansson and A T Bergenheim
Br J Cancer 94: 1853-1863; advance online publication, May 30, 2006; doi:10.1038/sj.bjc.6603190
Molecular Diagnostics
Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy FREE
M F Gjerstorff, L E Johansen, O Nielsen, K Kock and H J Ditzel
Br J Cancer 94: 1864-1873; doi:10.1038/sj.bjc.6603163
A loss of c-kit expression is associated with an advanced stage and poor prognosis in breast cancer FREE
S Tsutsui, K Yasuda, K Suzuki, H Takeuchi, T Nishizaki, H Higashi and S Era
Br J Cancer 94: 1874-1878; advance online publication, May 23, 2006; doi:10.1038/sj.bjc.6603183
FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients FREE
S Streit, D S Mestel, M Schmidt, A Ullrich and C Berking
Br J Cancer 94: 1879-1886; advance online publication, May 23, 2006; doi:10.1038/sj.bjc.6603181
Real-time PCR analysis of a 3895 bp mitochondrial DNA deletion in nonmelanoma skin cancer and its use as a quantitative marker for sunlight exposure in human skin FREE
A Harbottle and M A Birch-Machin
Br J Cancer 94: 1887-1893; advance online publication, May 23, 2006; doi:10.1038/sj.bjc.6603178
Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatment FREE
K Mimori, N Sadanaga, Y Yoshikawa, K Ishikawa, M Hashimoto, F Tanaka, A Sasaki, H Inoue, K Sugimachi and M Mori
Br J Cancer 94: 1894-1897; advance online publication, May 23, 2006; doi:10.1038/sj.bjc.6603182
Identification of serum biomarkers for colon cancer by proteomic analysis FREE
D G Ward, N Suggett, Y Cheng, W Wei, H Johnson, L J Billingham, T Ismail, M J O Wakelam, P J Johnson and A Martin
Br J Cancer 94: 1898-1905; advance online publication, June 6, 2006; doi:10.1038/sj.bjc.6603188
Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients FREE
C Le Page, I H Koumakpayi, M Alam-Fahmy, A-M Mes-Masson and F Saad
Br J Cancer 94: 1906-1912; advance online publication, May 23, 2006; doi:10.1038/sj.bjc.6603184
Detection of adeno-associated virus type 2 genome in cervical carcinoma FREE
B Y Zheng, X D Li, F Wiklund, S Chowdhry, T Ångstrom, G Hallmans, J Dillner and K L Wallin
Br J Cancer 94: 1913-1917; advance online publication, May 30, 2006; doi:10.1038/sj.bjc.6603179
Genetics and Genomics
Mutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemia FREE
B U Mueller, T Pabst, P Hauser, G Gilliland, D Neuberg and D G Tenen
Br J Cancer 94: 1918-1920; advance online publication, May 30, 2006; doi:10.1038/sj.bjc.6603198
Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population FREE
F Lesueur, H Song, S Ahmed, C Luccarini, C Jordan, R Luben, D F Easton, A M Dunning, P D Pharoah and B A J Ponder
Br J Cancer 94: 1921-1926; advance online publication, May 9, 2006; doi:10.1038/sj.bjc.6603160
Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer FREE
B P Coe, W W Lockwood, L Girard, R Chari, C MacAulay, S Lam, A F Gazdar, J D Minna and W L Lam
Br J Cancer 94: 1927-1935; advance online publication, May 16, 2006; doi:10.1038/sj.bjc.6603167
Production and upregulation of granulocyte chemotactic protein-2/CXCL6 by IL-1
and hypoxia in small cell lung cancer FREE
Y M Zhu, S M Bagstaff and P J Woll
Br J Cancer 94: 1936-1941; advance online publication, May 23, 2006; doi:10.1038/sj.bjc.6603177
Sensitivity of markers of DNA stability and DNA repair activity to folate supplementation in healthy volunteers FREE
G P Basten, S J Duthie, L Pirie, N Vaughan, M H Hill and H J Powers
Br J Cancer 94: 1942-1947; advance online publication, May 30, 2006; doi:10.1038/sj.bjc.6603197
Letters to the Editor
BK virus and carcinoma of the prostate, kidney and bladder FREE
D B Weinreb
Br J Cancer 94: 1948; doi:10.1038/sj.bjc.6603124
Reply: Antibody levels against BK virus and prostate, kidney and bladder cancers in the EPIC-Oxford cohort FREE
R Newton, P Coursaget and I S D Roberts
Br J Cancer 94: 1949-1950; doi:10.1038/sj.bjc.6603125
Indexes
Author Index for Volume 94 FREE
Br J Cancer 94: 1951-1959; doi:10.1038/sj.bjc.6603217
Keyword Index for Volume 94 FREE
Br J Cancer 94: 1960-1963; doi:10.1038/sj.bjc.6603218
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
